Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 17060586.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We assessed the concentration of the oxcarbazepine metabolite 10-hydroxycarbazepine (MHD) in nine pregnancies among seven women before, during, and after pregnancy. The mean dose-corrected concentration of MHD was decreased during pregnancy (analysis of variance, p = 0.0016), being 72% (SD = 13%) in the first trimester, 74% (SD = 17%) in the second trimester, 64% (SD = 6%) in the third trimester, and 108% (SD = 18%) after pregnancy vs the dose-corrected concentration before pregnancy.
Medical subject headings
- Anticonvulsants
- Carbamazepine
- Epilepsy
- Pregnancy Complications